Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NEET: Nicotinamide Riboside and Exercise in Hypertensive Older Adults
NCT04112043Phase 1Completed
- Sponsor
- University of Florida
- Start
- Jul 2020
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of nicotinamide riboside in hypertension (HTN) (3 arms), sponsored by University of Florida. Primary endpoint: Change in Daytime Systolic Blood Pressure at 6 weeks. Started Jul 2020; status: completed.
02
Drugs
nicotinamide riboside
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT04112043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04112043.